Journal Article

Ten-Year Predicted Coronary Heart Disease Risk in HIV-Infected Men and Women

Robert C. Kaplan, Lawrence A. Kingsley, A. Richey Sharrett, Xiuhong Li, Jason Lazar, Phyllis C. Tien, Wendy J. Mack, Mardge H. Cohen, Lisa Jacobson and Stephen J. Gange

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 45, issue 8, pages 1074-1081
Published in print October 2007 | ISSN: 1058-4838
Published online October 2007 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/521935
Ten-Year Predicted Coronary Heart Disease Risk in HIV-Infected Men and Women

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Background. Highly active antiretroviral therapy (HAART), in addition to traditional vascular risk factors, may affect coronary heart disease (CHD) risk in individuals with human immunodeficiency virus (HIV) infection.

Methods. Among HIV-infected (931 men and 1455 women) and HIV-uninfected (1099 men and 576 women) adults, the predicted risk of CHD was estimated on the basis of age, sex, lipid and blood pressure levels, the presence of diabetes, and smoking status.

Results. Among HIV-infected men, 2% had moderate predicted risk of CHD (10-year CHD risk, 15%–25%), and 17% had high predicted risk (10-year CHD risk of ⩾25% or diabetes). Among HIV-infected women, 2% had moderate predicted CHD risk, and 12% had high predicted CHD risk. Compared with users of protease inhibitor–based HAART, the adjusted odds ratio (OR) for moderate-to-high risk of CHD was significantly lower among HAART-naive individuals (OR, 0.57; 95% confidence interval [CI], 0.36–0.89). Users of HAART that was not protease inhibitor based (OR, 0.74; 95% CI, 0.53–1.01) and former HAART users (OR, 0.68; 95% CI, 0.46–1.03) were also less likely than users of protease inhibitor–based HAART to have moderate-to-high CHD risk, although 95% CIs overlapped the null. Low income was associated with increased likelihood of moderate-to-high CHD risk (for annual income <$10,000 vs. >$40,000: OR, 2.32; 95% CI, 1.51–3.56 ). Elevated body mass index (calculated as weight in kilograms divided by the square of height in meters) predicted increased likelihood of moderate-to-high CHD risk (for BMI of 18.5–24.9 vs. BMI of 25–30: OR, 1.41 [95% CI, 1.03–1.93]; for BMI of 18.5–24.9 vs. BMI ⩾30: OR, 1.79 [95% CI, 1.25–2.56]).

Conclusions. Among HIV-infected adults, in addition to antiretroviral drug exposures, being overweight and having a low income level were associated with increased predicted CHD risk. This suggests a need to target HIV-infected men and women with these characteristics for vascular risk factor screening.

Journal Article.  4217 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.